Latest news and press releases:


20/09/2017                                                                                                 


Lonza Introduces the New CytoSMART™ 2 System for Live Cell Imaging read more>> 


Recipharm to make clinical trial cancer candidate for Kancera read mroe>>


FDA's Janet Woodcock: the clinical trials system is 'broken' read more>>


Sanofi tests three-in-one antibody to treat or prevent HIV read more>>


Shire, Shionogi's ADHD drug for adults clears late-stage trial in Japan read more>>


GSK gets FDA approval for key triple therapy inhaler read more>> 


19/09/2017                                                                                                 


AbbVie and Roche plan Venclexta combo filings in leukaemia read more>> 


Teva sells women's health division to tackle $35bn debts read more>>


Planning teams forming as Thermo Fisher completes $7.2bn Patheon acquisition read more>>


New lab space to support CRO’s acceleration into 2018 read more>>


FDA approves Trelegy Ellipta inhaler for GlaxoSmithKline, Innoviva read more>> 


18/09/2017                                                                                                 


Bayer’s rare cancer drug Aliqopa bags speedy approval read more>> 


NICE rejects first-line use of Roche’s Gazyvaro read more>> 


Immunocore and Bill and Melinda Gates Foundation collaboration read more>> 


Novartis' Xolair shows strong retreatment efficacy at Phase 3 in chronic spontaneous urticaria read more>> 


15/09/2017                                                                                                 


QuintilesIMS Announces Launch of Secondary Public Offering and Repurchase of Common Stock read more>> 


FDA clears first-ever medical app that helps kick drug addiction read more>>


FDA approves first-ever biosimilar for cancer treatment read more>> 


Novo highlights key ‘hypo’ data from Tresiba at EASD read more>>


14/09/2017                                                                                                 


Evotec and MaRS Innovation establish Academic Bridge "LAB150" in Toronto read more>> 


Pfizer, Astellas prostate cancer drug promising in late-stage trial read more>>


GSK lines up a shot at a blockbuster market as new CEO prepares to tackle Merck rival head on read more>>


Pfizer boosts Ibrance's class with positive neutropenia data read more>> 


AstraZeneca’s Forxiga displays potential in type 1 diabetes read more>> 


Alexion to Restructure Operations, to Lower Headcount by 20% read more>> 


Roche (RHHBY) Announces Data on Respiratory Drug Esbriet read more>> 


13/09/2017                                                                                                 


Alexion's Headquarters Relocation Stings In New Haven read more>>


Scott Gottlieb is closing a big loophole in the orphan drug law read more>>


FDA grants fast-track designation for Shire's lung drug read more>> 


12/09/2017                                                                                                 


Roche under pressure as second rituximab biosimilar filed in US read more>>


Alexion preps big layoffs and a move to Boston/Cambridge read more>>


Shire gets US FDA fast track designation for lung disease drug read more>> 


Novartis says biosimilar rituximab accepted for review by FDA read more>>


11/09/2017                                                                                                 


PAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments read more>> 


Lonza Consumer Care Launches Online "Survive the BPR™" Knowledge Centre read more>> 


Merck's Keytruda extends survival edge on its bladder cancer rivals read more>> 


GSK exercises global licence option for Adaptimmune’s NY-ESO-1 T-cell therapy read more>>


AstraZeneca lung cancer trial results impress but risks remain, analysts say read more>>


Teva appoints Lundbeck’s Kare Schultz as CEO read more>>


Regeneron and Sanofi receive FDA’s breakthrough therapy status for CSCC treatment with cemiplimab read more>>


Catalent to make opioid withdrawal candidate for US approval read more>>


Sanofi and Regeneron announce positive dupilumab topline results read more>>


24/08/2017                                                                                                 


Lonza to Increase and Expand Capabilities for Drug Product Services for Parenteral Dosage Forms read more>> 


Digital-minded Novartis taps Apple's ResearchKit for smartphone MS study read more>> 


Novartis receives EU approval for breast cancer drug Kisqali read more>>


Roche says FDA grants priority review to hemophilia drug emicizumab read more>>


AstraZeneca drug reduces risk of repeat heart attack by almost a third read more>>


23/08/2017                                                                                                 


GVK BIO RECEIVES BEST LIFE SCIENCES QHSE LEADERSHIP INDIA 2017 read more>> 


GlaxoSmithKline partners with Alibaba for China HPV vaccine market grab read more>>  


NICE rejects thyroid cancer drugs read more>> 


India grants Pfizer patent on pneumonia vaccine in blow to aid group read more>>


Envigo eyes public market capital in Avista merger read more>>


22/08/2017                                                                                                 


Jubilant receives NDA approval for Drax Exametazime read more>> 


PAREXEL and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan read more>> 


AstraZeneca strikes mRNA-based partnership in respiratory disease read more>> 


Novartis launches MS smartphone trial read more>> 


$417 Million Awarded in Suit Tying Johnson’s Baby Powder to Cancer read more>>


Orphan drugs: overcoming barriers to market access read more>>


17/08/2017                                                                                                 


Inaugural Charles River World Congress on Animal Models in Drug Discovery & Development to Explore Trends in Reverse Translational Medicine read more>> 


AZ looks to pay-for-performance to bolster cardio-diabetes franchise read more>>


BASF outlines plans for $50m Mumbai R&D campus read more>> 


Evotec completes Aptuit acquisition read more>>


16/08/2017                                                                                                 


After a slow start, Novartis finally gains market traction with heart drug Entresto read more>> 


Sanofi and Regeneron end ten-year mAb collaboration read more>>


FDA grants orphan drug status to H3 Biomedicine’s cancer treatment read more>>


14/08/2017                                                                                                 


Mylan launches three generic anti-retroviral treatments for HIV patients in Canada read more>>


NICE expands Merck KGaA’s Erbitux reach read more>> 


GSK walks away from Ionis antisense drugs read more>> 


NICE turns down kidney cancer drugs read more>> 


Oxford BioMedica enters Innovate UK-backed agreement read more>> 


10/08/2017         &nb

© 2017 The World of CROs. All rights reserved.

  • theworldofCROs

    First COPD patient treated with RejuvenAir System in a multicenter clinical trial bit.ly/3m1YDPC

    21st October @ 07:28
  • theworldofCROs

    Brain imaging biomarker may help predict treatment response in patients with psychiatric disorders, study reveals bit.ly/34hhHni

    21st October @ 07:27
  • theworldofCROs

    Here's how Bristol Myers' CEO Giovanni Caforio completed a $13B buyout: He moved fast, upped the bid quickly and de… twitter.com/i/web/status/1…

    21st October @ 07:25
  • theworldofCROs

    Roche drops $500M into new global operations hub, with 500 jobs to follow bit.ly/34fzk6B

    21st October @ 07:22
  • theworldofCROs

    Roche hit by 'high-end' biosimilar attack as Ocrevus, Tecentriq bounce back from COVID-19 slowdown bit.ly/2H3x0XM

    16th October @ 07:08